CME vs TROW Comparison: AI Score, Valuation, Performance and Upside
Compare CME Group's futures exchange toll-taking model against T. Rowe Price's active fund management fee business.
Use this CME Group vs T. Rowe Price comparison to evaluate the key differences across valuation, growth, profitability, and risk before making an investment decision.
CME holds the edge across 4 of 5 key metrics in this comparison. CME has delivered stronger 1-year price return (+7.39% vs +1.50%), though TROW has the better forward P/E setup (10.81x vs 22.10x for CME). On fundamentals, TROW is growing revenue faster (10.70%), while CME maintains the higher operating margin (65.04%) — a classic growth-versus-profitability split. Analyst consensus implies similar upside for both: -0.96% for CME and -1.49% for TROW.
Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.
| Metric | CME | TROW |
|---|---|---|
| AI scorei | 46.5 | 39.8 |
| AI ranki | #692 | #1168 |
| Latest closei | $281.29 | $109.78 |
| 1M returni | +6.69% | -3.72% |
| 6M returni | -11.85% | +21.24% |
| 1Y returni | +7.39% | +1.50% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | CME | TROW |
|---|---|---|
| 1Y ago | $10.71K (+7.1%) started 2025-09-08 | $10.15K (+1.5%) started 2025-09-08 |
| 5Y ago | $20.59K (+105.9%) started 2021-09-09 | $6.95K (-30.5%) started 2021-09-09 |
| 10Y ago | $55.32K (+453.2%) started 2016-09-09 | $31.57K (+215.7%) started 2016-09-09 |
Hypothetical — past performance does not guarantee future results.
| Metric | CME | TROW |
|---|---|---|
| Market capi | $102.77B | $23.73B |
| Trailing P/Ei | 24.22 | 11.17 |
| Forward P/Ei | 22.10 | 10.81 |
| Price/Salesi | 15.75 | 2.92 |
| EV/Revenuei | 15.44 | 2.91 |
| Analyst targeti | $283.07 | $109.58 |
| Target upsidei | -0.96% | -1.49% |
| Metric | CME | TROW |
|---|---|---|
| Revenue growthi | 0.80% | 10.70% |
| Earnings growthi | 2.50% | 28.60% |
| EPS growthi | +2.50% | +28.60% |
| FCF margini | +43.05% | +26.66% |
| Operating margini | 65.04% | 28.69% |
| Profit margini | 63.44% | 29.26% |
| ROIC proxyi | 15.80% | 19.40% |
| Return on equityi | 15.80% | 19.40% |
| Dividend yieldi | 1.82% | 4.67% |
| Betai | 0.27 | 1.48 |
| Debt/equityi | 14.59 | 3.70 |
| Current ratioi | 1.02 | 4.04 |
| Quick ratioi | 0.02 | 4.04 |
Over the past year, CME and TROW have moved barely in opposite directions (correlation of -0.00), based on daily returns.
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | CME | TROW |
|---|---|---|---|
| 1Y | Growthi | +7.13% | +1.49% |
| CAGRi | +7.14% | +1.49% | |
| Volatilityi | 23.80% | 24.11% | |
| Sharpe ratioi | 0.22 | -0.00 | |
| Sortino ratioi | 0.30 | -0.01 | |
| Max drawdowni | 33.05% | 20.93% | |
| Current drawdowni | 13.84% | 9.78% | |
| Avg drawdowni | 9.03% | 6.66% | |
| Ulcer Indexi | 12.55% | 8.46% | |
| Max daily dropi | 5.77% | 6.31% | |
| Max wkly dropi | 11.49% | 12.21% | |
| 5Y | Growthi | +71.97% | -41.03% |
| CAGRi | +11.46% | -10.03% | |
| Volatilityi | 20.79% | 30.72% | |
| Sharpe ratioi | 0.41 | -0.34 | |
| Sortino ratioi | 0.58 | -0.48 | |
| Max drawdowni | 33.05% | 57.89% | |
| Current drawdowni | 13.84% | 42.40% | |
| Avg drawdowni | 11.13% | 42.22% | |
| Ulcer Indexi | 14.37% | 43.60% | |
| Max daily dropi | 5.77% | 8.18% | |
| Max wkly dropi | 11.49% | 14.83% | |
| 10Y | Growthi | +271.68% | +121.30% |
| CAGRi | +14.04% | +8.27% | |
| Volatilityi | 24.23% | 30.12% | |
| Sharpe ratioi | 0.48 | 0.27 | |
| Sortino ratioi | 0.67 | 0.38 | |
| Max drawdowni | 37.36% | 58.16% | |
| Current drawdowni | 13.84% | 42.78% | |
| Avg drawdowni | 9.23% | 25.00% | |
| Ulcer Indexi | 12.61% | 31.97% | |
| Max daily dropi | 18.39% | 13.07% | |
| Max wkly dropi | 27.51% | 24.82% |
| Category | CME | TROW |
|---|---|---|
| Company | CME | TROW |
| Sector | Financial Services | Financial Services |
| Industry | Financial Data & Stock Exchanges | Asset Management |
| Core business | CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. | T. Rowe Price Group, Inc. is a publicly owned investment manager. |
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.
Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.